Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any Leber congenital amaurosis in which the cause of the disease is a mutation in the AIPL1 gene.
Features include sometimes findings: Keratoconus. 10 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 6 | Keratoconus, Pendular nystagmus, Blindness |
Muscles | 1 | Macular atrophy |
AIPL1 encodes AIP like 1 HSP90 co-chaperone (384 aa). May be important in protein trafficking and/or protein folding and stabilization Highest expression in Testis (0.8 TPM) and Spleen (0.1 TPM).
Leber congenital amaurosis 4 is associated with mutations in the AIPL1 gene on chromosome 17.
AIPL1 is classified as a druggable target (Druggable Genome category) with score 0.0.
Genetic testing for AIPL1 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for Leber congenital amaurosis 4 has been reported in the published literature.
7 clinical trials registered, 4 recruiting. Interventions under study include other interventions, drug therapy, medical devices, and procedural interventions. Pipeline includes 1 PHASE2, 2 PHASE1, 2 NA. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT04285398](https://clinicaltrials.gov/study/NCT04285398) |
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 1:47 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Common questions about Leber congenital amaurosis 4
Prospective Natural History Study of Retinitis Pigmentosa |
NA |
SparingVision |
ACTIVE_NOT_RECRUITING |
[NCT06789445](https://clinicaltrials.gov/study/NCT06789445) | A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO) | PHASE1 | BlueRock Therapeutics | RECRUITING |
[NCT03011541](https://clinicaltrials.gov/study/NCT03011541) | Stem Cell Ophthalmology Treatment Study II | NA | MD Stem Cells | RECRUITING |
[NCT05748873](https://clinicaltrials.gov/study/NCT05748873) | Promising ROd-cone DYstrophy Gene therapY | PHASE1 | SparingVision | ACTIVE_NOT_RECRUITING |
[NCT01773278](https://clinicaltrials.gov/study/NCT01773278) | Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome (SLOS) | PHASE2 | University of Colorado, Denver | UNKNOWN |
124 publications have been identified in PubMed for Leber congenital amaurosis 4. Research spans Case Report / Case Series (27%), Basic Science / Preclinical (27%), and Epidemiology / Natural History (24%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 33 | 27% |
Laboratory research | 33 | 27% |
Disease patterns and progression | 30 | 24% |
Research summaries | 16 | 13% |
Testing and diagnosis research | 6 | 5% |
New treatment approaches | 5 | 4% |
Clinical study results | 1 | 1% |
Sun C (2026). [PMID: 41993427](https://pubmed.ncbi.nlm.nih.gov/41993427/). *bioRxiv*. [Epidemiology / Natural History]
Kwok JC (2026). [PMID: 39428496](https://pubmed.ncbi.nlm.nih.gov/39428496/). *Vet Ophthalmol*. [Case Report / Case Series]
Donovan K (2026). [PMID: 41920593](https://pubmed.ncbi.nlm.nih.gov/41920593/). *Retin Cases Brief Rep*. [Diagnostic / Biomarker]
Park J (2026). [PMID: 42231409](https://pubmed.ncbi.nlm.nih.gov/42231409/). *BMC Med Genomics*. [Case Report / Case Series]
Massengill MT (2026). [PMID: 41595470](https://pubmed.ncbi.nlm.nih.gov/41595470/). *Genes (Basel)*. [Basic Science / Preclinical]
Bhattacharya S (2026). [PMID: 42193986](https://pubmed.ncbi.nlm.nih.gov/42193986/). *Biomolecules*. [Review / Meta-Analysis]
Takács Á (2026). [PMID: 41595520](https://pubmed.ncbi.nlm.nih.gov/41595520/). *Genes (Basel)*. [Epidemiology / Natural History]
Ekemiri K (2026). [PMID: 41760155](https://pubmed.ncbi.nlm.nih.gov/41760155/). *BMJ Open*. [Review / Meta-Analysis]
Pagán-Melvin C (2026). [PMID: 41841063](https://pubmed.ncbi.nlm.nih.gov/41841063/). *Cureus*. [Case Report / Case Series]
Josan AS (2026). [PMID: 41237986](https://pubmed.ncbi.nlm.nih.gov/41237986/). *Am J Ophthalmol*. [Basic Science / Preclinical]